Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T13:37:15.938Z.
Calculation as of: 2026-10-06T13:37:15.938Z.
Quote observation: 2026-10-06T13:34:58.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 934548bd97ab8c390298f716fcf622fc2d1107cfab085c47b2b47650fd31fbc6
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Market Cap
$711.27M
Price/FCF Ratio
2.17
TTM Avg
4.81
3Y Avg
5.21
5Y Avg
6.10
Market Cap
$657.34M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$729.24M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$721.69M
Price/FCF Ratio
N/A
TTM Avg
4.42
3Y Avg
4.41
5Y Avg
4.41
Market Cap
$644.17M
Price/FCF Ratio
1268.04
TTM Avg
742.47
3Y Avg
742.47
5Y Avg
415.90
Market Cap
$751.75M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Helus Pharma Inc. (HELP) | $696.39M | N/A | N/A | N/A | N/A |
| Faeth Therapeutics, Inc. (FTH)vs › | $684.30M | N/A | N/A | N/A | N/A |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $711.27M | 2.17 | 4.81 | 5.21 | 6.10 |
| Annexon, Inc. (ANNX)vs › | $675.03M | N/A | N/A | N/A | N/A |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $657.34M | N/A | N/A | N/A | N/A |
| Anteris Technologies Global Corp. (AVR)vs › | $729.24M | N/A | N/A | N/A | N/A |
| Achieve Life Sciences, Inc. (ACHV)vs › | $721.69M | N/A | 4.42 | 4.41 | 4.41 |
| AngioDynamics, Inc. (ANGO)vs › | $644.17M | 1268.04 | 742.47 | 742.47 | 415.90 |
| Candel Therapeutics, Inc. (CADL)vs › | $751.75M | N/A | N/A | N/A | N/A |
| Aura Biosciences, Inc. (AURA)vs › | $639.24M | N/A | N/A | N/A | N/A |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
